JP Morgan Private Wealth Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,260	Closed	-$163K	–	1470
2019 Q2	$163K	Hold	6,260	–	–	﹤0.01%	1310
2019 Q1	$161K	Hold	6,260	–	–	﹤0.01%	1389
2018 Q4	$144K	Sell	6,260 -697	-10%	-$19.7K	﹤0.01%	1372
2018 Q3	$223K	Hold	6,957	–	–	﹤0.01%	1432
2018 Q2	$197K	Buy	6,957 +1,720	+33%	+$61.2K	﹤0.01%	1376
2018 Q1	$185K	Hold	5,237	–	–	﹤0.01%	1193
2017 Q4	$203K	Hold	5,237	–	–	﹤0.01%	1184
2017 Q3	$133K	Hold	5,237	–	–	﹤0.01%	1186
2017 Q2	$143K	Buy	5,237 +197	+4%	+$5.39K	﹤0.01%	1176
2017 Q1	$167K	Sell	5,040 -10	-0.2%	-$255	﹤0.01%	1265
2016 Q4	$120K	Sell	5,050 -369	-7%	-$10.6K	﹤0.01%	1201
2016 Q3	$199K	Buy	5,419 +709	+15%	+$20.3K	﹤0.01%	1147
2016 Q2	$105K	Hold	4,710	–	–	﹤0.01%	1207
2016 Q1	$98K	Hold	4,710	–	–	﹤0.01%	1138
2015 Q4	$143K	Hold	4,710	–	–	﹤0.01%	1055
2015 Q3	$116K	Sell	4,710 -50	-1%	-$1.49K	﹤0.01%	983
2015 Q2	$153K	Hold	4,760	–	–	﹤0.01%	996
2015 Q1	$170K	Buy	+4,760	New	+$131K	﹤0.01%	1061

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Private Wealth Advisors's RIGL Position: Q3 2019 in Review

JP Morgan Private Wealth Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q3 2019, closing a stake of 6,260 shares — an estimated $163K sold.

JP Morgan Private Wealth Advisors first reported a position in RIGL in Q1 2015 and held it in 18 quarters. The position peaked at $223K in Q3 2018. 131 funds tracked by Wall St. Rank hold RIGL as of Q3 2019.

JP Morgan Private Wealth Advisors reported no remaining Rigel Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 6,260 Rigel Pharmaceuticals shares in Q3 2019, an estimated $163K.
JP Morgan Private Wealth Advisors first reported a position in Rigel Pharmaceuticals in Q1 2015 and held it in 18 quarters.
JP Morgan Private Wealth Advisors's Rigel Pharmaceuticals position peaked at $223K in Q3 2018.
131 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.